Cookies and Cream | Cannabis Strain Review & Effects
Starfighter x GSC phenotype
Cookies and Cream is a hybrid strain (Starfighter x GSC phenotype) with THC levels of 20-26%. It features a Beta-Caryophyllene-dominant terpene profile and is known for relaxed and happy. Best used during the afternoon.
THC
20-26%
CBD
0-1%
Best Time
Primary Effects
Flavor Notes
Sweet, Vanilla, Creamy, Nutty
Aroma
Sweet aroma with vanilla and nutty notes
Research Sources
29 peer-reviewed studies
Verified Via
PubMed / DOI
Evidence
Research-Backed
Updated
December 2025
What is Cookies and Cream?
Cookies and Cream is a hybrid strain (Starfighter x GSC phenotype) with THC levels of 20-26%. It features a Beta-Caryophyllene-dominant terpene profile and is known for relaxed and happy. Best used during the afternoon.
About Cookies and Cream Strain
Cookies and Cream is a balanced hybrid cannabis strain created by crossing Starfighter x GSC phenotype, bred by Exotic Genetix. With THC levels ranging from 20% to 26%, Cookies and Cream is considered a high-potency strain that delivers powerful effects. Cookies and Cream has earned recognition, including Cannabis Cup winner.
Users of Cookies and Cream commonly report feeling relaxed, happy, euphoric, uplifted. The effects provide a balanced experience, starting with gentle mental stimulation before transitioning into full-body relaxation. This makes Cookies and Cream versatile for various situations and times of day. The balanced nature of this strain makes it well-suited for afternoon use when you want relaxation without excessive sedation.
Medical cannabis patients frequently turn to Cookies and Cream for relief from stress, anxiety, depression, chronic pain. The caryophyllene content may provide anti-inflammatory and analgesic benefits, as this terpene interacts directly with CB2 receptors in the endocannabinoid system.
Cookies and Cream is considered beginner-friendly, making it accessible for those new to cannabis or with lower tolerance levels. Start with a small dose and wait at least 15-30 minutes before consuming more, especially when trying this strain for the first time. Common side effects may include dry mouth, dry eyes. Staying well-hydrated and having snacks on hand can help minimize discomfort.
The aroma of Cookies and Cream is characterized by sweet, vanilla, nutty notes that create a distinctive sensory profile. On the palate, expect sweet, vanilla, creamy flavors that develop throughout each session. The caryophyllene-dominant terpene profile is largely responsible for these aromatic and flavor characteristics, contributing to the entourage effect that shapes the overall experience.
Related Reading
Commonly Used For
Patients often seek Cookies and Cream for relief from the following conditions:
Note: These are commonly reported uses based on patient experiences. Individual results may vary. Always consult with a healthcare provider to determine if medical cannabis is appropriate for your specific condition.
Potential Side Effects
Be aware of these commonly reported side effects when using Cookies and Cream:
How to minimize side effects
- Start with a low dose, especially if new to cannabis
- Stay hydrated before, during, and after use
- Use in a comfortable, familiar environment
- Avoid mixing with alcohol or other substances
Terpene Profile
Primary research: Calming & Relaxation
Concentration Levels
Cannabinoid Profile
Therapeutic Profile Matches
Based on Cookies and Cream's terpene and cannabinoid profile, it may be well-suited for these therapeutic applications:
migraines
- High beta-caryophyllene content supports migraines & headaches
- High linalool content supports migraines & headaches
- thc dominant ratio matches profile
depression
- High beta-caryophyllene content supports depression
- High limonene content supports depression
- High linalool content supports depression
anxiety
- High limonene content supports anxiety
- High beta-caryophyllene content supports anxiety
- Best used afternoon, aligning with condition needs
nausea
- High limonene content supports nausea & appetite loss
- High beta-caryophyllene content supports nausea & appetite loss
- thc dominant ratio matches profile
multiple sclerosis
- High beta-caryophyllene content supports multiple sclerosis
- High linalool content supports multiple sclerosis
- Best used afternoon, aligning with condition needs
Match scores are theoretical
These scores are based on terpene/cannabinoid research and do not guarantee specific effects. Individual responses vary significantly. Always consult a healthcare provider.
- 1
Gertsch J, et al. β-Caryophyllene is a dietary cannabinoid Proceedings of the National Academy of Sciences. 2008
Landmark paper: BCP directly activates CB2 receptors.
- 2
Klauke AL, et al. The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain European Journal of Pain. 2014
Showed dual mechanism for neuropathic pain relief.
- 3
Bahi A, et al. β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice Physiology & Behavior. 2014
BCP reduced anxiety via CB2 receptor activation.
- 4
Horvath B, et al. β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner Free Radical Biology and Medicine. 2012
BCP reduced inflammation markers and oxidative stress.
- 5
Tambe Y, et al. Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene Planta Medica. 1996
BCP protected gastric mucosa in ulcer models.
- 6
Tagen M, et al. Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol Drug and Alcohol Dependence. 2024
Johns Hopkins study showing limonene specifically reduces THC-induced anxiety in humans.
- 7
Vieira AJ, et al. Limonene: Aroma of innovation in health and disease Chemico-Biological Interactions. 2018
Comprehensive review of limonene's anxiolytic and antidepressant effects.
- 8
Kiecolt-Glaser JK, et al. Olfactory influences on mood and autonomic, endocrine, and immune function Psychoneuroendocrinology. 2008
Lemon scent exposure improved mood and reduced norepinephrine.
- 9
Sun J. D-Limonene: safety and clinical applications Alternative Medicine Review. 2007
D-limonene showed gastroprotective effects and clinical safety.
- 10
Linck VM, et al. Effects of inhaled Linalool in anxiety, social interaction and aggressive behavior in mice Phytomedicine. 2010
Linalool reduced anxiety without motor impairment.
- 11
Harada H, et al. Linalool Odor-Induced Anxiolytic Effects in Mice Frontiers in Behavioral Neuroscience. 2018
Showed linalool acts via olfactory system and GABA-A receptors.
- 12
Koulivand PH, et al. Lavender and the nervous system: Clinical evidence Evidence-Based Complementary and Alternative Medicine. 2013
Review of linalool-rich lavender for anxiety and mood.
- 13
Linck VM, et al. Inhaled linalool-induced sedation in mice Phytomedicine. 2009
Linalool increased sleep time without affecting REM sleep.
- 14
Peana AT, et al. Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils Phytomedicine. 2002
Linalool reduced edema and inflammation in rat models.
- 15
Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish Journal of the American Chemical Society. 1964. doi:10.1021/ja01062a046
Landmark paper first identifying and synthesizing THC.
- 16
Whiting PF, et al. Cannabinoids for medical use: A systematic review and meta-analysis JAMA. 2015
Comprehensive review finding moderate evidence for chronic pain.
- 17
Aviram J, Samuelly-Leichtag G. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Pain Physician. 2017
Systematic review of clinical trials for neuropathic pain.
- 18
Lutge EE, et al. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS Cochrane Database of Systematic Reviews. 2013
Systematic review of cannabis for HIV/AIDS symptoms including appetite.
- 19
Smith LA, et al. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy Cochrane Database of Systematic Reviews. 2015
High-quality evidence for CINV efficacy.
- 20
Kesner AJ, Lovinger DM. Cannabinoids, Endocannabinoids and Sleep Frontiers in Molecular Neuroscience. 2020
Review of THC effects on sleep architecture.
- 21
Novotna A, et al. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis European Journal of Neurology. 2011
Phase III trial showing efficacy for MS spasticity.
- 22
Silvestro S, et al. Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease Molecules. 2020
Comprehensive review of CBD's therapeutic applications and molecular targets.
- 23
Thiele EA, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial Lancet. 2018
Phase III trial leading to FDA approval of Epidiolex.
- 24
Devinsky O, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial Lancet Neurology. 2016
Open-label trial showing 36.5% reduction in seizures.
- 25
Shannon S, et al. Cannabidiol in anxiety and sleep: A large case series Permanente Journal. 2019
79.2% of patients reported reduced anxiety within first month.
- 26
Bergamaschi MM, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients Neuropsychopharmacology. 2011
CBD reduced anxiety in simulated public speaking test.
- 27
Burstein S. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation Bioorganic & Medicinal Chemistry. 2015
Review of CBD's anti-inflammatory mechanisms.
- 28
Shannon S, et al. Cannabidiol in Anxiety and Sleep: A Large Case Series Permanente Journal. 2019
66.7% of patients reported improved sleep in this anxiety and sleep study.
- 29
Urits I, et al. Use of cannabidiol (CBD) for the treatment of chronic pain Best Practice & Research Clinical Anaesthesiology. 2020
Comprehensive review of CBD for chronic pain management.
Research Verification
All citations link directly to PubMed or the original source. You can verify any claim by clicking the reference link. Learn more about how we research.
Frequently Asked Questions
What are the effects of Cookies and Cream?
Cookies and Cream is known for producing relaxed, happy, euphoric, uplifted effects. As a hybrid, it's typically best suited for afternoon use. This strain is considered beginner-friendly.
What conditions might Cookies and Cream help with?
Cookies and Cream is commonly used by patients seeking relief from stress, anxiety, depression, chronic pain. Always consult with a healthcare provider before using cannabis for medical purposes.
How strong is Cookies and Cream?
Cookies and Cream is considered a high-potency strain with THC levels typically ranging from 20-26%. Despite its potency, it's considered accessible for most users when dosed appropriately.
What does Cookies and Cream taste and smell like?
Cookies and Cream features sweet, vanilla, creamy flavors with a sweet, vanilla, nutty aroma. Its unique terpene combination creates a memorable sensory experience.
What are the side effects of Cookies and Cream?
Common side effects include dry mouth, dry eyes. Staying hydrated and starting with a low dose can help minimize these effects.
Quick Facts
- Type
- Hybrid
- Genetics
- Starfighter x GSC phenotype
- Breeder
- Exotic Genetix
- Genetic Family
- Cookies/Gelato Family
- Best Time of Use
- Afternoon
- Availability
- common
- Grow Difficulty
- moderate
- Experience Level
- Beginner Friendly
Dominant Terpene
Beta-Caryophyllene
Spicy, peppery, woody, clove-like
Want to try Cookies and Cream? Get your medical marijuana card today.
Get Your CardSimilar Strains
If you like Cookies and Cream, try these
Related by Genetics
Educational Information
This content is for educational purposes only and is not medical advice. Consult a healthcare provider before using cannabis products.
Strain Variability
Profiles vary between batches, growers, and growing conditions. Always check lab test results for the specific product you're purchasing.
Beyond Indica/Sativa
Effects are better predicted by cannabinoid and terpene profiles than strain classification. Focus on the chemistry, not the label.
Understanding Therapeutic Profiles
Learn how terpenes and cannabinoids work together to create each strain's unique effects and therapeutic potential through the entourage effect.
Learn About Therapeutic Profiles